A detailed history of Leavell Investment Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 17,756 shares of AMGN stock, worth $4.7 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
17,756
Previous 12,431 42.84%
Holding current value
$4.7 Million
Previous $3.88 Million 47.3%
% of portfolio
0.29%
Previous 0.22%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$309.38 - $337.38 $1.65 Million - $1.8 Million
5,325 Added 42.84%
17,756 $5.72 Million
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $39,938 - $48,535
-152 Reduced 1.21%
12,431 $3.88 Million
Q1 2024

Apr 24, 2024

SELL
$268.87 - $324.56 $34,684 - $41,868
-129 Reduced 1.01%
12,583 $3.58 Million
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $338,546 - $381,921
1,324 Added 11.63%
12,712 $3.66 Million
Q3 2023

Oct 16, 2023

SELL
$218.65 - $271.46 $79,151 - $98,268
-362 Reduced 3.08%
11,388 $3.06 Million
Q2 2023

Jul 19, 2023

BUY
$214.27 - $253.37 $21,855 - $25,843
102 Added 0.88%
11,750 $2.61 Million
Q1 2023

Apr 13, 2023

SELL
$225.79 - $275.2 $59,834 - $72,928
-265 Reduced 2.22%
11,648 $2.82 Million
Q4 2022

Jan 17, 2023

SELL
$229.03 - $291.01 $57,257 - $72,752
-250 Reduced 2.06%
11,913 $3.13 Million
Q3 2022

Oct 17, 2022

SELL
$224.46 - $253.15 $11,223 - $12,657
-50 Reduced 0.41%
12,163 $2.74 Million
Q2 2022

Jul 28, 2022

BUY
$230.71 - $256.74 $6,690 - $7,445
29 Added 0.24%
12,213 $2.97 Million
Q1 2022

Apr 21, 2022

BUY
$219.27 - $242.57 $44,073 - $48,756
201 Added 1.68%
12,184 $2.95 Million
Q4 2021

Jan 20, 2022

SELL
$198.88 - $227.6 $4,773 - $5,462
-24 Reduced 0.2%
11,983 $2.7 Million
Q3 2021

Oct 26, 2021

BUY
$212.27 - $248.7 $32,265 - $37,802
152 Added 1.28%
12,007 $2.55 Million
Q1 2021

Apr 15, 2021

BUY
$221.91 - $258.6 $49,485 - $57,667
223 Added 1.92%
11,855 $2.95 Million
Q4 2020

Jan 26, 2021

SELL
$216.38 - $257.67 $37,866 - $45,092
-175 Reduced 1.48%
11,632 $2.67 Million
Q4 2019

Jan 22, 2020

BUY
$189.21 - $243.2 $94,605 - $121,600
500 Added 4.42%
11,807 $2.85 Million
Q3 2019

Oct 28, 2019

BUY
$174.11 - $208.62 $112,649 - $134,977
647 Added 6.07%
11,307 $2.19 Million
Q2 2019

Jul 18, 2019

SELL
$166.7 - $195.41 $10,002 - $11,724
-60 Reduced 0.56%
10,660 $1.96 Million
Q1 2019

Apr 16, 2019

BUY
$180.87 - $203.88 $14,469 - $16,310
80 Added 0.75%
10,720 $2.04 Million
Q4 2018

Jan 24, 2019

BUY
$178.4 - $208.25 $30,149 - $35,194
169 Added 1.61%
10,640 $2.07 Million
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $2,779 - $3,133
-15 Reduced 0.14%
10,471 $2.17 Million
Q2 2018

Jul 23, 2018

BUY
$166.05 - $186.51 $10,793 - $12,123
65 Added 0.62%
10,486 $1.94 Million
Q1 2018

Apr 25, 2018

SELL
$169.43 - $198.0 $25,414 - $29,700
-150 Reduced 1.42%
10,421 $1.78 Million
Q4 2017

Jan 11, 2018

SELL
$168.79 - $188.59 $350,239 - $391,324
-2,075 Reduced 16.41%
10,571 $1.84 Million
Q3 2017

Oct 25, 2017

BUY
$167.29 - $191.0 $2.12 Million - $2.42 Million
12,646
12,646 $2.36 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Leavell Investment Management, Inc. Portfolio

Follow Leavell Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Leavell Investment Management, Inc. with notifications on news.